Skip to main content

HER2 Receptor Antagonists

HER2 receptor antagonists are used to treat breast cancer. They work by targeting cancer cells that express HER2.

Why are her2 receptor antagonists prescribed?

  1. Stomach Cancer (50%)
  2. Breast Cancer (50%)

Key takeaways

HER2 antagonists are used to treat many HER2-positive cancers, such as HER2-positive breast cancer, gastric cancer, and non-small cell lung cancer. These medications work by targeting the human epidermal growth factor receptor 2 (HER2) on cancer cells, which helps to slow or stop the growth of these cells. HER2 antagonists are usually given as injections or infusions. Examples include Herceptin (trastuzumab), Perjeta (pertuzumab), and Enhertu (fam-trastuzumab deruxtecan-nxki).

Prices for popular HER2 Receptor Antagonists medications
Viewing 12 of 12 medications
Hercessi is part of the HER2 Receptor Antagonists class and treats Stomach Cancer and Breast Cancer. HER2 receptor antagonists are used to treat breast cancer. They work by targeting cancer cells that express HER2. Hercessi is only available as a brand name drug.
MARGETUXIMAB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.
vial icon

Ogivri

as low as$2,519
Ogivri (trastuzumab-dkst) is used to treat stomach and breast cancer. Ogivri is a HER2 Receptor Antagonist, which works by targeting cancer cells that express HER2. The most common form of Ogivri is a 150mg vial. It is also available as a 420mg vial. Ogivri is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. It may be covered by some Medicare and insurance plans.
vial icon

Herzuma

as low as$2,930
Herzuma (trastuzumab-pkrb) is used to treat stomach and breast cancer. Herzuma is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Herzuma may be covered by your Medicare or insurance plan.
Ontruzant (trastuzumab-dttb) is used to treat stomach and breast cancer. Ontruzant is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Ontruzant may be covered by your Medicare or insurance plan.
Kanjinti (trastuzumab-anns) is used to treat stomach and breast cancer. Kanjinti is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Kanjinti may be covered by your Medicare or insurance plan.
Trazimera (trastuzumab-qyyp) is used to treat stomach and breast cancer. Trazimera is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Trazimera may be covered by your Medicare or insurance plan.
vial icon

Phesgo

as low as$13,325
PERTUZUMAB; TRASTUZUMAB; HYALURONIDASE treats breast cancer. Pertuzumab and trastuzumab work by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. Hyaluronidase works by increasing the absorption of other medications in the body to help them work better. It is a combination medication that contains two monoclonal antibodies.
FAM-TRASTUZUMAB DERUXTECAN treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Herceptin (trastuzumab) is used to treat stomach and breast cancer. Herceptin is also available as a biosimilar. Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Herceptin may be covered by your Medicare or insurance plan.
ADO-TRASTUZUMAB EMTANSINE treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
PERTUZUMAB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By signing up, I agree to GoodRx’s Terms of Use and Privacy Policy, and to receive marketing messages from GoodRx.

Latest Articles

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.